Skip to main content
Clinical Trials/NCT00846378
NCT00846378SuspendedPhase 1

The Mechanism of Ischemic Post-conditioning in Humans: Minimizing Reperfusion Injury in Patients With Acute Myocardial Infarction

University of Cincinnati2 sites in 1 country30 target enrollmentStarted: March 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Suspended
Enrollment
30
Locations
2
Primary Endpoint
Quantitation of infarct size will be done using a modification of University Hospital's standard Single-photon emission computed tomography (SPECT) quantitation software

Study Overview

Brief Summary

The size of a heart attack will be decreased by the use of timed balloon inflations to open the blocked blood vessel.

Detailed Description

The intervention of "post conditioning" at the time of reperfusion, in patients with acute myocardial infarction (AMI), will attenuate the degree of ischemia-reperfusion injury, as manifested by infarct size. This intervention is hypothesized to be safe in humans.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Onset of symptoms within 6 hours
  • TIMI 0 to TIMI 1 flow in infarct related artery

Exclusion Criteria

  • collaterals to infarct related artery
  • previous infarct in related territory
  • thrombolytics
  • cardiogenic shock
  • TIMI 2 to TIMI 3 flow

Outcomes

Primary Outcomes

Quantitation of infarct size will be done using a modification of University Hospital's standard Single-photon emission computed tomography (SPECT) quantitation software

Time Frame: 6 weeks

Echocardiograms will be analyzed to evaluate left ventricular function. Standard techniques will be used to quantitate ejection fraction and the percentage of left ventricular circumference that is hypokinetic or dyskinetic.

Time Frame: 6 weeks

Venous blood samples troponin, creatine phosphokinase (CPK). This will be done to follow enzyme release and washout, and area data will be available and infarct size/risk area ratios in control and post-conditioning subjects will be compared.

Time Frame: baseline, every 8 hours x 3

ECG ST segment resolution immediate post percutaneous coronary intervention(PCI), and daily x 3.

Time Frame: baseline, up to 3 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tarek Helmy

Professor

University of Cincinnati

Study Sites (2)

Loading locations...

Similar Trials